Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
about
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®)Patient preferences in severe COPD and asthma: a comprehensive literature reviewA systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers?Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerPatient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.Advances in device and formulation technologies for pulmonary drug delivery.Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian populationPreference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre studyPatient-centered care and its effect on outcomes in the treatment of asthma.A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.Long-acting muscarinic antagonists.Development of Respimat(®) Soft Mist™ Inhaler and its clinical utility in respiratory disorders.Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.
P2860
Q26738366-D4347345-088E-4B4B-97A0-32BD055045C7Q27004230-FC9F88DF-F61F-4D10-A3CD-A8814A9B8E83Q30820402-C300345F-6045-4B4C-AB6A-D280864BD0FBQ30836841-BB06C026-CA0B-4D53-85AE-89298D13229DQ33693426-D15F943C-BB77-4C1F-9831-E97E6273376DQ33883565-93B8AA54-A809-4E13-A706-DDC23102AA36Q33962567-47D4D78D-9091-4B7A-A0F5-39F8DB1FDB44Q34309072-C5547523-C8BA-4016-ADA3-FB88296E3EE6Q34453118-2EEC23F7-AEC8-4806-B0B2-150E8873AC7DQ35556510-D2A34855-E2BB-4DCB-A92E-09039CE83294Q36160630-BA7A21A4-C937-48DD-94D9-85C0BE137875Q36648904-F445AD5F-AB55-42BD-9998-7C2F30B22C5EQ36813641-BD75A864-97BE-41AB-986E-C547FAD69631Q38537326-3D3A7AD5-A4B6-444E-BBF5-423AE9CF192CQ42119060-401E19C2-AB0F-44BC-A449-D1FA18A6DB53Q50026720-32661C4A-CB4E-49A4-8D5D-2B5714A8934C
P2860
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@en
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@nl
type
label
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@en
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@nl
prefLabel
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@en
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@nl
P2093
P2860
P356
P1476
Asthma patients prefer Respimat Soft Mist Inhaler to Turbuhaler.
@en
P2093
Pat Ray Reese
Rick Hodder
Terra Slaton
P2860
P304
P356
10.2147/COPD.S3452
P407
P577
2009-06-11T00:00:00Z